Synthetic Biology – News and Features

Lignin is an abundant byproduct of paper manufacturing that could be broken down to form compounds usually sourced from petroleum, reports a new study.

Despite the unappealing origins of the fake meat, burgers derived from different fungi species have become supermarket staples in recent years thanks to rising consumer interest in environmental sustainability and meat-free lifestyles.

Rice University synthetic biologists have found a way to piggyback on the glucose monitoring technology used in automated insulin dosing systems and make it universally applicable for the monitoring and dosing of virtually any drug.

Featuring research from the Doudna laboratory, the University of Harvard and the Center for Advanced Bioenergy and Bioproducts Innovation, this round-up piece discusses the latest research advancements in CRISPR technology.

In a new study, researchers describe the development of a new technological platform that will enhance the accuracy and efficiency of drug discovery related to a large family of important pharmacological targets.

Encouraging scientists to rethink the materials and methods they use will help to foster a culture of sustainability within research institutions and across various industries. Technology Networks spoke with Dr. Joel Eichmann from Green Elephant Biotech to learn more about the creation of its plant-based plastic labware, and his broader vision for embedding sustainability within the biotech industry.

Join us as we explore how innovation, ethics and even aesthetics look set to influence the landscape of life science research, creating new possibilities for treating human diseases, feeding our growing population and nurturing the scientists of the future.

Cornell researchers have created a new version of a microbe to compete economically with E. coli to conduct low-cost and scalable synthetic biological experiments.

In this interview, Dr. Jason Park, co-founder and CEO of Empress Therapeutics, tells us more about the Chemilogics platform and the benefits this approach to drug discovery can offer.

Researchers have successfully coaxed a deadly pathogen to destroy itself from the inside out. In the new study, researchers modified DNA from a bacteriophage or “phage,” a type of virus that infects and replicates inside of bacteria.